Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana R Sousa

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
International Forum of Allergy & Rhinology|March 4, 2022
The roles of eosinophils and interleukin-5 in the pathophysiology of chronic rhinosinusitis with nasal polypsPhilippe Gevaert, Joseph K Han, Steven G Smith, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Understanding the Patient Experience of Severe, Recurrent, Bilateral Nasal Polyps: A Qualitative Interview Study in the United States and GermanyRebecca Hall, Claire Trennery, Robert Chan, et al.
Progress in Molecular Biology and Translational Science|July 19, 2025
Advanced energy storage systems as power sources for biosensing technologiesClara R Pereira, André M Pereira, Joana S Teixeira, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2017
Severe asthma: Differential chemokine response of airway epithelial cellsBiju Thomas, Robert Anthony Hirst, Mina H Brett-Pitt, et al.
ERJ Open Research|June 24, 2026
Cardiovascular events in patients with COPD after long-acting bronchodilator initiationDave Singh, Ana R Sousa, David E Newby, et al.
OTO Open|October 17, 2022
Elucidating the Real-World Burden of Chronic Rhinosinusitis With Nasal Polyps in Patients in the USAVictoria S Benson, Guillaume Germain, Robert H Chan, et al.
Advances in Therapy|November 3, 2017
Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized StudyGregory J Feldman, Ana R Sousa, David A Lipson, et al.
Journal of Patient-Reported Outcomes|January 20, 2023
Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE studyWytske Fokkens, Andrew Trigg, Stella E Lee, et al.
OTO Open|December 22, 2023
Patient-Reported Outcome Measures for Severe Recurrent Bilateral Nasal Polyps: Psychometric Evaluation and Content ValidityAdam Gater, Chloe Tolley, Rebecca Williams-Hall, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 16, 2023
Mepolizumab Reduces Systemic Corticosteroid Use in Chronic Rhinosinusitis With Nasal PolypsGeoffrey Chupp, Isam Alobid, Njira L Lugogo, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
International Forum of Allergy & Rhinology|March 4, 2022
The roles of eosinophils and interleukin-5 in the pathophysiology of chronic rhinosinusitis with nasal polypsPhilippe Gevaert, Joseph K Han, Steven G Smith, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Understanding the Patient Experience of Severe, Recurrent, Bilateral Nasal Polyps: A Qualitative Interview Study in the United States and GermanyRebecca Hall, Claire Trennery, Robert Chan, et al.
Progress in Molecular Biology and Translational Science|July 19, 2025
Advanced energy storage systems as power sources for biosensing technologiesClara R Pereira, André M Pereira, Joana S Teixeira, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2017
Severe asthma: Differential chemokine response of airway epithelial cellsBiju Thomas, Robert Anthony Hirst, Mina H Brett-Pitt, et al.
ERJ Open Research|June 24, 2026
Cardiovascular events in patients with COPD after long-acting bronchodilator initiationDave Singh, Ana R Sousa, David E Newby, et al.
OTO Open|October 17, 2022
Elucidating the Real-World Burden of Chronic Rhinosinusitis With Nasal Polyps in Patients in the USAVictoria S Benson, Guillaume Germain, Robert H Chan, et al.
Advances in Therapy|November 3, 2017
Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized StudyGregory J Feldman, Ana R Sousa, David A Lipson, et al.
Journal of Patient-Reported Outcomes|January 20, 2023
Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE studyWytske Fokkens, Andrew Trigg, Stella E Lee, et al.
OTO Open|December 22, 2023
Patient-Reported Outcome Measures for Severe Recurrent Bilateral Nasal Polyps: Psychometric Evaluation and Content ValidityAdam Gater, Chloe Tolley, Rebecca Williams-Hall, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 16, 2023
Mepolizumab Reduces Systemic Corticosteroid Use in Chronic Rhinosinusitis With Nasal PolypsGeoffrey Chupp, Isam Alobid, Njira L Lugogo, et al.
Pageof 8